Libo Yao
La Jolla Institute for Allergy and Immunology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Libo Yao.
Molecular and Cellular Biology | 1994
Yuko Kawakami; Libo Yao; Toru Miura; S Tsukada; O N Witte; Toshiaki Kawakami
Tyrosine phosphorylation of several cellular proteins is one of the earliest signaling events induced by cross-linking of the high-affinity receptor for immunoglobulin E (Fc epsilon RI) on mast cells or basophils. Tyrosine kinases activated during this process include the Src family kinases, Lyn, c-Yes, and c-Src, and members of another subfamily, Syk and PTK72 (identical or highly related to Syk). Recently, some of us described two novel tyrosine kinases, Emb and Emt, whose expression was limited to subsets of hematopoietic cells, including mast cells. Emb turned out to be identical to Btk, a gene product defective in human X-linked agammaglobulinemia and in X-linked immunodeficient (xid) mice. Here we report that Fc epsilon RI cross-linking induced rapid phosphorylation on tyrosine, serine, and threonine residues and activation of Btk in mouse bone marrow-derived mast cells. A small fraction of Btk translocated from the cytosol to the membrane compartment following receptor cross-linking. Tyrosine phosphorylation of Btk was not induced by either a Ca2+ ionophore (A23187), phorbol 12-myristate 13-acetate, or a combination of the two reagents. Co-immunoprecipitation between Btk and receptor subunit beta or gamma was not detected. The data collectively suggest that Btk is not associated with Fc epsilon but that its activation takes place prior to protein kinase C activation and plays a novel role in the Fc epsilon RI signaling pathway.
Journal of Biological Chemistry | 1997
Libo Yao; Hidefumi Suzuki; Koichiro Ozawa; Jianbei Deng; Csaba Lehel; Hiromi Fukamachi; Wayne B. Anderson; Yuko Kawakami; Toshiaki Kawakami
Pleckstrin homology (PH) domains comprised of loosely conserved sequences of ∼100 amino acid residues are a functional protein motif found in many signal-transducing and cytoskeletal proteins. We recently demonstrated that the PH domains of Tec family protein-tyrosine kinases Btk and Emt (equal to Itk and Tsk) interact with protein kinase C (PKC) and that PKC down-regulates Btk by phosphorylation. In this study we have characterized the PKC-BtkPH domain interaction in detail. Using pure PKC preparations, it was shown that the Btk PH domain interacts with PKC with high affinity (K D = 39 nm). Unlike other tested phospholipids, phosphatidylinositol 4,5-bisphosphate, which binds to several PH domains, competed with PKC for binding to the PH domain apparently because their binding sites on the amino-terminal portion of the PH domains overlap. The minimal PKC-binding sequence within the Btk PH domain was found to correspond roughly to the second and third β-sheets of the PH domains of known tertiary structures. On the other hand, the C1 regulatory region of PKCε containing the pseudosubstrate and zinc finger-like sequences was found to be sufficient for strong binding to the Btk PH domain. Phorbol 12-myristate 13-acetate (PMA), a potent activator of PKC that interacts with the C1 region of PKC, inhibited the PKC-PH domain interaction, whereas the bioinactive PMA (4-α-PMA) was ineffective. The ζ isoform of PKC, which has a single zinc finger-like motif instead of the two tandem zinc finger-like sequences present in conventional and novel PKC isoforms, does not bind PMA. Thus, as expected, PH domain binding with PKCζ was not interfered with by PMA. Further, inhibitors that are known to attack the catalytic domains of serine/threonine kinases did not affect this PKC-PH domain interaction. In contrast, the presence of physiological concentrations of Ca2+ induced less than a 2-fold increase in PKC-PH domain binding. These results indicate that PKC binding to PH domains involve the β2–β3 region of the Btk PH domain and the C1 region of PKC, and agents that interact with either of these regions (i.e. phosphatidylinositol 4,5-bisphosphate binding to the PH domain and PMA binding to the C1 region of PKC) might act to regulate PKC-PH domain binding.
Proceedings of the National Academy of Sciences of the United States of America | 2003
Yuko Kawakami; Jiro Kitaura; Libo Yao; Robert W. McHenry; Yu Kawakami; Alexandra C. Newton; Shin Kang; Roberta M. Kato; Michael Leitges; David J. Rawlings; Toshiaki Kawakami
Protein kinase C (PKC) and Syk protein tyrosine kinase play critical roles in immune cell activation including that through the high-affinity IgE receptor, FcεRI. Mechanisms by which PKC activation leads to the activation of Ras, a family of GTPases essential for immune cell activation, have been elusive. We present evidence that Tyr-662 and Tyr-658 of PKCβI and PKCα, respectively, are phosphorylated by Syk in the membrane compartment of FcεRI-stimulated mast cells. These phosphorylations require prior PKC autophosphorylation of the adjacent serine residues (Ser-661 and Ser-657, respectively) and generate a binding site for the SH2 domain of the adaptor protein Grb-2. By recruiting the Grb-2/Sos complex to the plasma membrane, these conventional PKC isoforms contribute to the full activation of the Ras/extracellular signal-regulated kinase signaling pathway in FcεRI-stimulated mast cells.
Journal of Leukocyte Biology | 1999
Yuko Kawakami; Jiro Kitaura; Daisuke Hata; Libo Yao; Toshiaki Kawakami
Brutons tyrosine kinase (Btk) plays crucial roles in B cell differentiation as well as mast cell activation through the high‐affinity IgE receptor (Fc∊RI). Defects in the btk gene lead to agammaglobulinemia (XLA) in humans and X‐linked immunodeficiency (xid) in mice. Mast cells from xid and btk null mice exhibit mild defects in degranulation and severe impairments in the production of proinflammatory cytokines upon Fc∊RI cross‐linking. Recent studies demonstrated the role of Btk in a sustained increase in intracellular calcium concentrations in response to antigen receptor stimulation. Btk is also involved in the activation of stress‐activated protein kinases, JNK/SAPK1/2, and thereby regulates c‐Jun and other transcription factors that are important in cytokine gene activation. Regulation of the JNK/SAPK activation pathway by Btk may be related to the proapoptotic function of Btk in the programmed cell death in these hematopoietic cells. J. Leukoc. Biol. 65: 286–290; 1999.
Immunology Letters | 1996
Yuko Kawakami; Libo Yao; Wei Han; Toshiaki Kawakami
Tec family protein-tyrosine kinases (PTKs) have been recognized as a distinct subfamily for only a few years. Two of them, Btk and Emt, are tyrosine-phosphorylated and enzymatically activated upon cross-linking of the high-affinity IgE receptor (Fc epsilonRI), suggesting their involvement in mast cell activation. Since Lyn and other Src family PTKs phosphorylate Btk at Tyr-551 and activate the latter kinase, the receptor-associated Lyn seems to activate Btk in mast cells. The Btk kinase activity, on the other hand, is regulated negatively by phosphorylation by protein kinase C (PKC) that is associated with Btk via Btks pleckstrin homology (PH) domain. PH domains also bind to phospholipids and the beta subunit of heterotrimeric GTP-binding proteins. Therefore, it has been hypothesized that PH domains play roles in membrane localization.
Archive | 1999
Toshiaki Kawakami; Libo Yao; Yuko Kawakami
“The completion of the budding yeast genome sequence project has made it possible to determine not only the total number of genes, but also the exact number of genes of a particular type. As a consequence, we now know exactly how many protein kinases are encoded by the yeast genome, a number of considerable interest because of the importance of protein phosphorylation in the control of so many cellular processes.”1 Activation of the immune cells, including mast cells, is a typical cellular process that is under the control of the intricate phosphorylation network composed of both protein tyrosine kinases (PTKs) and serine/threonine kinases, among many types of signaling molecules.
Proceedings of the National Academy of Sciences of the United States of America | 1994
Libo Yao; Yuko Kawakami; Toshiaki Kawakami
Journal of Experimental Medicine | 1998
Daisuke Hata; Yuko Kawakami; Naoki Inagaki; Chris S. Lantz; Toshio Kitamura; Wasif N. Khan; Mari Maeda-Yamamoto; Toru Miura; Wei Han; Stephen E. Hartman; Libo Yao; Hiroichi Nagai; Anne E. Goldfeld; Frederick W. Alt; Stephen J. Galli; Owen N. Witte; Toshiaki Kawakami
Proceedings of the National Academy of Sciences of the United States of America | 1997
Yuko Kawakami; Toru Miura; Reid P. Bissonnette; Daisuke Hata; Wasif N. Khan; Toshio Kitamura; Mari Maeda-Yamamoto; Stephen E. Hartman; Libo Yao; Frederick W. Alt; Toshiaki Kawakami
Journal of Biological Chemistry | 1999
Libo Yao; Paul A. Janmey; Luciano G. Frigeri; Wei Han; Jun Fujita; Yuko Kawakami; John R. Apgar; Toshiaki Kawakami